SARS-CoV-2
Ag Ultra

Lab-comparable results in just 5 minutes.

Verify potential infection quickly with a rapid microfluidic assay that provides actionable and lab-comparable results for patients suspected of COVID-19 in just 5 minutes.

Test benefits

  • Microfluidic immunofluorescence assay
  • Results in 5 minutes
  • Optimize clinical workflow
  • Sample type: nasal swab
  • Easy to implement at point of care
    • No refrigeration storage required: room temperature storage (2-30°C)
    • Small and portable Instrument
    • Minimal handling steps

Test workflow

The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning correctly for every test run.

The workflow process is comprised of a simple sample prep along with step-by-step guidance of the Instrument to report a patient result in under 5 minutes from sample application.

The LumiraDx SARS-CoV-2 Ag Test workflow process is comprised of a simple sample prep along with step-by-step guidance of the Instrument to report a patient result
COMPLIANCE DOCUMENTS

Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets. Available in the USA under Emergency Use Authorization for SARS-COV-2 assays.

BetterHealthExperiencesOutcomes

Supporting healthier lives, for individuals, communities and wider society

Enabling responsive, personal relationships between patients and care teams.

Controlling and reducing costs to help ease pressure on healthcare budgets.

Be Informed

SIGN UP FOR NEWS